Company / Operating Income
Aurinia Pharmaceuticals Inc. Operating Income History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$104.9M
FY2025
5-year range
-$104.3M / $104.9M
FY2021-FY2025
Trend
+2338.4%
vs FY2024
Sector context
#36 of 204
Health Care
What the data says
Operating Income changed +2338% YoY in FY2025, a notable deviation from the 7-year average annual change of +338%.
Based on SEC 10-K filings.
$105M in FY2025. Top quartile in the Health Care sector.
Improved from -$92M to $105M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Health CareTop 18% of 204This company $104.9M Sector average $107.8M
▼
-2.6% below sector average
Key checks
Key Insights
- Aurinia Pharmaceuticals Inc.'s operating income has grown for 3 consecutive years.
- In FY2025, operating income increased 2338.4% year-over-year.
- Ranks #36 out of 204 companies in the Health Care sector.
- Lowest operating income in the period was in FY2022.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $104.9M | +2338.4% |
| FY2024 | -$4.7M | +94.9% |
| FY2023 | -$91.7M | +12.1% |
| FY2022 | -$104.3M | -14.7% |
| FY2021 | -$90.9M | +12.8% |
| FY2020 | -$104.3M | -14.7% |
| FY2019 | -$90.9M | -64.6% |
| FY2018 | -$55.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026